Neurocytotron on Cerebral Palsy

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

March 22, 2019

Primary Completion Date

December 15, 2022

Study Completion Date

March 22, 2023

Conditions
Cerebral Palsy
Interventions
DEVICE

Neurocytotron

Neurocytotron utilizes a combination of instantaneous magnetic field and low-spectrum radiofrequency waves for therapeutic purpose. Its working principle is based on the theory of magnetic resonance.

DEVICE

Placebo

Same treatment procedures without being actually exposed to electromagnetic waves and magnetic field

Trial Locations (1)

66224

NeuroCytonix México, Monterrey

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

KCRN Research, LLC

INDUSTRY

lead

Neurocytonix, Inc.

INDUSTRY

NCT03743623 - Neurocytotron on Cerebral Palsy | Biotech Hunter | Biotech Hunter